{"name":"Kymera Therapeutics, Inc.","slug":"kymera-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxNa2c5RWVob0UwcGplR2dISkJpNldIUlJNdDRxRVU3aWdFNU4wcFVXcGd0SUVGa2QxdGJfdzNkbmp1Nlk5aVNZWlBWZE9MalY5UXhiaHFFTHljblpNMGdSejd5SUhSaFNTYjRqSVVaems0S3N6TU5jZ0pFWjFrcHBJbE5RbGtDUzBnaEZGeWN5Z1Q5MFlXRkNacDMwUV9tTVNPUnM3a21SRlFsajJaUVp6OFhwMWFrRWdWTFZDQlR2U2E4V01XLVhZVnZhd2tmeUp6QWZjdkh2azZodk9EdktCR1VVUWJFa0hLSU1OVG1TdWJxZHBaTWhNN2o1VF8yYjBCV2VuQWpXOGQ?oc=5","date":"2026-03-31","type":"pipeline","source":"Benzinga","summary":"Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving High - Benzinga","headline":"Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving High","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQOE5yNTlzRVdGdTZUTmZ1Qk10NWdqa1ROQWRoQUpZYzFKSFVpTTR0YTF6MmxrQzdRbUFldkZUOVhqb29JdmtRdm83UmJDTmx0d2txeEpqNWpXUGdVYnpLVDBtU0MtRkR2cTFjZWpFcEplUGJaUjFGZ1U1M0tJeHdRcmo1eVlKcjRDa0tYd29B?oc=5","date":"2026-03-03","type":"deal","source":"Pharmaceutical Technology","summary":"Kairos Pharma signs deal for Celyn Therapeutics’ CL-273 - Pharmaceutical Technology","headline":"Kairos Pharma signs deal for Celyn Therapeutics’ CL-273","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQLUQ1OE55Mk9aVVkycjFzRXE0dXNPVFVxbk9iYU9vdGFQQnp5Rk0zVFNucVlfUkxLc3FzVHBxT1RDYUl6cExZbjlOaGNhMlloaWEyVXRCM2M3V2lfYncyUk55b1RWNVhnb1UtTjBodU5wZ0lIX3VLNTU1a0JiZUZ5TkJDcFJfeXNubDZHMklTNWYxQlNRWlFZ?oc=5","date":"2026-01-15","type":"deal","source":"BioWorld News","summary":"Muted and missing M&As: JPM deals absent in 2026 - BioWorld News","headline":"Muted and missing M&As: JPM deals absent in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPRFBOa0FSR2pibVFMaHRVU3k4dFhaUm1MTWJvdjUxR2Vfem9mMWkzQUJZcW5UQkhnNi1PWU5vVkVlSF96UDBiWU42Wl9BN05PZ0NwdkN4TDhQalpwc3RFbXJiUXVrUkU1RFJrbGJnZFA3cGJkSUo1bDhkRVBhMExrN1VOYU4xeFBWZ25Bd0pKTFlOTVZKc3IyMzRIRGxMdGxl?oc=5","date":"2025-12-09","type":"trial","source":"Finviz","summary":"KYMR Stock Surges on Upbeat Data From KT-621 Atopic Dermatitis Study - Finviz","headline":"KYMR Stock Surges on Upbeat Data From KT-621 Atopic Dermatitis Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxObk5RS2RtVmpEa19mV25rcnlfZnBHSWFYd1FZc3Zua3RndE94NW0tU3UxeWdzMjAxZ08ycnpJdk9aTUc5UWN0dkNNeFlxV2lkalVkeG50ejVqUkdhN2hRTUZmMENyVHVuOXl1NWpPa1JhdXRLTVEzVU5RZ252YXc4X1cyRTMyak1NbG5iNXJkZ21FZDVf?oc=5","date":"2025-12-08","type":"pipeline","source":"Barron's","summary":"Kymera Therapeutics Stock Heads for Record. Investors Are Excited by Its Anti-Inflammatory Drug. - Barron's","headline":"Kymera Therapeutics Stock Heads for Record. Investors Are Excited by Its Anti-Inflammatory Drug. - Barron's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxQdEFnQktFM210eXdiZmRhVlE4Y3FUTndfak5Cell5OFgyR1Z1QWxsaks4TzU0NTBvZlJIc0o3enpwWTlTYXBFR3o4eFZNZUg2QUpEZGN5Z3ZsTFRqTmZOMVBSZVpoa1YxT3ZHbFlaVVJOZHBWZjFkSE1jSFpXSVVpYVl2U1VhSHRJS1daVHZkSHAtLW5nbW1aeWZIZk9CQUxLNnVlYVF6VVZNRVdtT3ZpVzhMVkI1ODFPLUpqLWpBU3dEVnpWSldBX1JaTmZaX1VTUFJEc0hubWtXZGVwWmw4UmlyLUpTbk5MYVhCRENwaVByRVhzZXhobF9wUGJNYzUtMGNzWEFqbkN3enFKdFplVjJnYzVPQVduMDAzZ1Jn?oc=5","date":"2025-12-08","type":"regulatory","source":"globenewswire.com","summary":"Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma - globenewswire.com","headline":"Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPWlV2b3NOalppYzZPUkR3TXVQRnFzaEtMV0hwekFOYTZGdDAwUlZULUtmZzY1UnlRU2Z4YkZTb3d1LWZSNU5ibmhOLU84a1JjemNSRC1oUzkxQkotbTNvSHFJR2tEa2YzNGpsR2NBN19KQVpXb0g0aTVWOExUdHpQY0w3RU9RcUgwcnpNWVF2NlQ3QV9LSkwzSG9odzFQQQ?oc=5","date":"2025-09-11","type":"pipeline","source":"Pharmafile","summary":"Brian Adams appointed as Kymera’s CLO and Corporate Secretary - Pharmafile","headline":"Brian Adams appointed as Kymera’s CLO and Corporate Secretary","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxOczRPeVFySmxqRE5RUmV6c3p3a3h4TFJxYzhLSGlXcjZDSERrQWtQc1BfSUwxbEFlS0wxckIwZmtjaElqcWVYN2JHVFhDZmwxVFFwMVVQQjdxMDJ2SnVxSjYydzhxbm1yWmNJZ1ZuQVE1ZUNzVzZ1NUhzU2pSMmhfMERvbmR2azZsbVdTNWVwRDlJVU05dnI2LVJiRmVBS1h5bnVUOVFXSGlyc3FsTVZmcVk0bVJFRTVxVkk4bjh2QTd2OHBRY0EzTUs1Sl91RWQzWGFNeW9pazI?oc=5","date":"2025-06-25","type":"deal","source":"reuters.com","summary":"Gilead signs up to $750 million cancer drug deal with Kymera Therapeutics - reuters.com","headline":"Gilead signs up to $750 million cancer drug deal with Kymera Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOMldSNkdjaDBmaHRWd2J1UUw4WUhDTjloS05MVlhPeXROU2x6M3Q1UnlNZTdROGpzb0N4ZTRncWNJMEFUOVd5aXN1TW5yRExmZURzN3RsMTgyWHVhOVlGU01CVVpudEhwNTNxUXBZaVBQRWE0WDg4ZmxJdnVHZ3ZYNW5kQjNPbW5kcWJaTGNmcEc1ZDA?oc=5","date":"2025-06-25","type":"deal","source":"BioPharma Dive","summary":"Kymera adds Gilead as research partner, while advancing new candidate with Sanofi - BioPharma Dive","headline":"Kymera adds Gilead as research partner, while advancing new candidate with Sanofi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQZlY0Ti1hVWZidjNzR1Z5SVZxTC1MMGtEQmtoMTdHSzlSUE8yS1FqdVZ3SDVoWnY4UWw4ZFl5ZjFiNEdFb1RnNUxialVIYmxwVFlKdXl5WGUza3hVZ05kWmRtRVJHNVpEbmNIV2NhOTZmdUdCekJBT3BfMGNLOTFhUFVpbkJfUllZbmJFMXhSOXNFZw?oc=5","date":"2025-06-25","type":"deal","source":"Contract Pharma","summary":"Gilead & Kymera Partner on Novel Cancer Drug - Contract Pharma","headline":"Gilead & Kymera Partner on Novel Cancer Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQaWMtcDlCa3lTQzNaU2xtOU9IMVFxX1Fqck1PbVZOdjFoajJKVTVFZWxRSVZPeEJMWDN5bUlJZkhmeF9YOUlyVWlmNUZvTjNmXzN4aTJ1SGdQTFd2djVoUUpXZTNUUDdRZk45UGFsTlZEUllmSUhyMU9tMDNZREdOMkFFSG9zaG9vNXBYNDZleGNBWWl1UzJieTIzZ0JJLXhqR1AwbmdWY0Nkc3ZKSlE?oc=5","date":"2025-06-25","type":"deal","source":"Seeking Alpha","summary":"Kymera Shrugs Off Sanofi Bust With Gilead Deal - But There Are Caveats (NASDAQ:KYMR) - Seeking Alpha","headline":"Kymera Shrugs Off Sanofi Bust With Gilead Deal - But There Are Caveats (NASDAQ:KYMR)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOb2UtODFiWVB0Tl9jQVdpcVRnWk9lOFpCcldrOGdpOUNhU2NkWlNpbGZuN3NvZHFxTHdwNW9maFR2c2JEUjNlSHhaNm5VY1dUeHFyNkdHdjF0Mmw1aDZuNDBDZndpUW5YUFRFOGlPU1I1QWY0a3FJVUpqc2htWkJrblU5NWx2NERjc2lkTkZpa190TVlBSVdmUi16MjlPYVU3TVlobThNa21qLUs1ZDh2dWJURThjdXNHRHhmc01JNA?oc=5","date":"2025-06-11","type":"pipeline","source":"BioCentury","summary":"Kymera’s STAT6 degrader breaks ahead of competition: BioCentury’s Clinical Report - BioCentury","headline":"Kymera’s STAT6 degrader breaks ahead of competition: BioCentury’s Clinical Report","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}